Adherence in Global Airways

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-12

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the relationship between long-term use of systemic steroids in patients with upper and lower respiratory tract diseases and their own production of cortisol (cross-sectional), as well as whether those with low cortisol levels have an impact on bone density. As patients with CRSwNP have a high use of steroids, they routinely undergo a DEXA scan at the Respiratory Clinic, Department of Ear-Nose-Throat Surgery and Audiology (ENT) - Rigshospitalet (RH) to examine whether their bone density and structure are affected. The scan will be included as a clinical secondary outcome to assess whether systemic steroid use has an impact on this.

The purpose of the study is therefore to compare steroid intake, baseline P-cortisol, the body's response to ACTH (measured by cortisol levels after the test), and bone density in patients with chronic sinusitis (CRS) with and without asthma in an unselected population at the Respiratory Clinic (cross-sectional). In addition, at the 4-month follow-up (exploratory follow-up, pilot project), it will be investigated whether good adherence (\>80%) to inhalation therapy (nasal steroid and lung steroid) and additional treatment with biologicals has a negative effect on the body's own production of P-cortisol.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP

NCT03963648

Chronic Rhinosinusitis (Diagnosis) Nasal Polyps Asthma +4 more

UNKNOWN NA

NCT05553951

Chronic Rhinosinusitis Without Nasal Polyps Asthma Chronic Rhinosinusitis With Nasal Polyps +1 more

ACTIVE_NOT_RECRUITING NA

Pre-operative Steroids in CRSsP

NCT05095961

Chronic Sinus Disease Chronic Sinusitis, Ethmoidal Chronic Sinusitis, Sphenoidal +2 more

WITHDRAWN PHASE2/PHASE3

Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study

NCT00841802

Chronic Sinusitis Rhinosinusitis Nasal Polyps

WITHDRAWN PHASE4

Effect of Postoperative Additive Systemic Steroids in CRSwNP

NCT04915456

Sinusitis, Chronic

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Rhinosinusitis Without Nasal Polyps Asthma Chronic Rhinosinusitis With Nasal Polyps Steroid-Induced Osteopenia (Diagnosis) Steroid-Induced Diabetes Steroid-Induced Hyperglycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cross sectional

The patients in the cross sectional study will have done a synactenstest to investigate how their own product of kortisol os after longterm use of systemic steroids.

The group consists of patients referred to the Respiratory Clinic, ENT, RH, for evaluation of CRS/CRSwNP/CRSnNP and with or without asthma for biological treatment. They are classified according to the type of inflammation they have (type-2 or non-type-2), whether they have CRSwNP or CRSsNP, their adherence, comorbidity with asthma, and finally the severity of the disease. All patients are given standard questionnaires to assess CRS/CRSwNP/CRSnNP and asthma (STARR-15, SNOT22, ACQ, ACT, MARS-5-L/N, Fosterscore - routine questionnaires for all patients in the Respiratory Clinic).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with chronic rhinosinusitis (CRS)
* possibly asthma
* Aged over 18 years

* Diagnosed with CRS and possibly asthma
* Age over 18 years
* Low adherence: Foster score, i.e. the number of treatments taken compared to prescribed \< 80% (4 weeks out of 16 weeks) and/or measured on MARS-5 L/N ≤35 at the first visit (corresponding to less than 80%). If the patient does not have asthma, it is MARS-5N ≤ 19
* If asthma: ACQ ≥1.2 or ACT ≤ 17 (partly uncontrolled asthma)
* SNOT-22 score ≥35 (partly uncontrolled CRS)
* Participation in the cross-sectional study at the initial visit to the Respiratory Clinic

Exclusion Criteria

* Unable to read or speak Danish
* Presence of severe psychiatric comorbidities
* Patients who have never taken systemic steroids
* Inability to participate or comply with local treatment according to the investigators' assessment
* Does not provide consent for lookup in FMK-online

Adherence:

* Foster score \>80% and/or on MARS-5-L/N \>35 points at the first visit
* Cannot read or speak Danish
* Severe psychiatric comorbidities
* Patients who have never taken systemic steroids
* After investigators' experience, will not be able to participate or comply with local treatment
* Does not give permission to look up data in FMK-online.

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes